ArticleBMC cancer2020

Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.

Takahiro Toyokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.